Evolent Health's GAAP loss for the 3 months of 2022 was $5.35 million, down 45.4% from $9.807 million in the prior year. Revenue increased 38.1% to $297.057 million from $215.071 million a year earlier.
Evolent Health's GAAP loss for the 3 months of 2022 was $5.35 million, down 45.4% from $9.807 million in the prior year. Revenue increased 38.1% to $297.057 million from $215.071 million a year earlier. 
ir.evolenthealth.com
English (US) 